157 related articles for article (PubMed ID: 6224605)
21. Interactions between 4-HPR and diet in NMU-induced mammary tumorigenesis.
Cohen LA; Epstein M; Saa-Pabon V; Meschter C; Zang E
Nutr Cancer; 1994; 21(3):271-83. PubMed ID: 8072880
[TBL] [Abstract][Full Text] [Related]
22. Antipromotional activity of dietary N-(4-hydroxyphenyl)retinamide in two-stage skin tumorigenesis in CD-1 and SENCAR mice.
McCormick DL; Moon RC
Cancer Lett; 1986 May; 31(2):133-8. PubMed ID: 2938725
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer prevention.
Cope MB; Steele VE; Lubet RA; Eto I; Juliana MM; Hill DL; Grubbs CJ
Oncol Rep; 2004 Feb; 11(2):465-9. PubMed ID: 14719085
[TBL] [Abstract][Full Text] [Related]
24. Influence of hormones on N-(4-hydroxyphenyl) retinamide inhibition of 7,12-dimethylbenz[alpha]anthracene transformation of mammary cells in organ culture.
Chatterjee M; Banerjee MR
Cancer Lett; 1982 Sep; 16(3):239-45. PubMed ID: 6217889
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapeutic evaluation of glucarate and N-(4-hydroxyphenyl)retinamide alone and in combination in the rat mammary tumor model.
Abou-Issa H; Webb TE; Minton JP; Moeschberger M
J Natl Cancer Inst; 1989 Dec; 81(23):1820-3. PubMed ID: 2531231
[TBL] [Abstract][Full Text] [Related]
26. Comparative chemopreventive activity of ibuprofen and N-(4-hydroxyphenyl) retinamide against the development and growth of rat mammary adenocarcinomas.
Alshafie GA; Harris RE; Robertson FM; Parrett ML; Ross M; Abou-Issa H
Anticancer Res; 1999; 19(4B):3031-6. PubMed ID: 10652588
[TBL] [Abstract][Full Text] [Related]
27. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells.
Bunk MJ; Kinahan JJ; Sarkar NH
Cancer Lett; 1985 Apr; 26(3):319-26. PubMed ID: 2986832
[TBL] [Abstract][Full Text] [Related]
28. N-Nitrosodiethylamine-induced nodule-like alveolar lesion and its prevention by a retinoid in BALB/c mouse mammary glands in the whole organ in culture.
Chatterjee M; Banerjee MR
Carcinogenesis; 1982; 3(7):801-4. PubMed ID: 6214328
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapeutic evaluation of N-(4-hydroxyphenyl) retinamide-O-glucuronide in the rat mammary tumor model.
Abou-Issa H; Curley RW; Panigot MJ; Tanagho SN; Sidhu BS; Alshafie GA
Anticancer Res; 1997; 17(5A):3335-9. PubMed ID: 9413168
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effect of N-(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer.
Dowlatshahi K; Mehta RG; Thomas CF; Dinger NM; Moon RC
Cancer Lett; 1989 Oct; 47(3):187-92. PubMed ID: 2534548
[TBL] [Abstract][Full Text] [Related]
31. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.
Sabichi AL; Modiano MR; Lee JJ; Peng YM; Xu MJ; Villar H; Dalton WS; Lippman SM
Clin Cancer Res; 2003 Jul; 9(7):2400-5. PubMed ID: 12855611
[TBL] [Abstract][Full Text] [Related]
32. Dietary retinoids and carotenoids in rodent models of mammary tumorigenesis.
Moon RC; Constantinou AI
Breast Cancer Res Treat; 1997; 46(2-3):181-9. PubMed ID: 9478273
[TBL] [Abstract][Full Text] [Related]
33. Effect of retinoid analogues on mammary cancer in transgenic mice with c-neu breast cancer oncogene.
Rao GN; Ney E; Herbert RA
Breast Cancer Res Treat; 1998 Apr; 48(3):265-71. PubMed ID: 9598873
[TBL] [Abstract][Full Text] [Related]
34. N-(4-hydroxyphenyl)-all-trans-retinamide pharmacokinetics in female rats and mice.
Hultin TA; May CM; Moon RC
Drug Metab Dispos; 1986; 14(6):714-7. PubMed ID: 2877832
[TBL] [Abstract][Full Text] [Related]
35. Changes associated with delay of mammary cancer by retinoid analogues in transgenic mice bearing c-neu oncogene.
Rao GN; Ney E; Herbert RA
Breast Cancer Res Treat; 1999 Dec; 58(3):241-54. PubMed ID: 10718486
[TBL] [Abstract][Full Text] [Related]
36. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat.
Moon RC; Thompson HJ; Becci PJ; Grubbs CJ; Gander RJ; Newton DL; Smith JM; Phillips SL; Henderson WR; Mullen LT; Brown CC; Sporn MB
Cancer Res; 1979 Apr; 39(4):1339-46. PubMed ID: 421218
[TBL] [Abstract][Full Text] [Related]
37. Dose-dependent suppression by the synthetic retinoid, 4-hydroxyphenyl retinamide, of streptococcal cell wall-induced arthritis in rats.
Haraoui B; Wilder RL; Allen JB; Sporn MB; Helfgott RK; Brinckerhoff CE
Int J Immunopharmacol; 1985; 7(6):903-16. PubMed ID: 3000963
[TBL] [Abstract][Full Text] [Related]
38. Effect of retinyl acetate and 4-hydroxyphenylretinamide on initiation of chemically-induced mammary tumors.
Grubbs CJ; Eto I; Juliana MM; Hardin JM; Whitaker LM
Anticancer Res; 1990; 10(3):661-6. PubMed ID: 2142393
[TBL] [Abstract][Full Text] [Related]
39. Subacute toxicity of all-trans- and 13-cis-isomers of N-ethyl retinamide, N-2-hydroxyethyl retinamide, and N-4-hydroxyphenyl retinamide.
Sani BP; Meeks RG
Toxicol Appl Pharmacol; 1983 Sep; 70(2):228-35. PubMed ID: 6226123
[TBL] [Abstract][Full Text] [Related]
40. Interaction of estrogen and prolactin in spontaneous mammary tumorigenesis of the mouse.
Welsch CW
J Toxicol Environ Health Suppl; 1976; 1():161-75. PubMed ID: 1036505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
